ID   CATB_HUMAN              Reviewed;         339 AA.
AC   P07858; B3KQR5; B3KRR5; Q503A6; Q96D87;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2005, sequence version 3.
DT   10-MAY-2017, entry version 202.
DE   RecName: Full=Cathepsin B;
DE            EC=3.4.22.1;
DE   AltName: Full=APP secretase;
DE            Short=APPS;
DE   AltName: Full=Cathepsin B1;
DE   Contains:
DE     RecName: Full=Cathepsin B light chain;
DE   Contains:
DE     RecName: Full=Cathepsin B heavy chain;
DE   Flags: Precursor;
GN   Name=CTSB; Synonyms=CPSB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-26.
RX   PubMed=3463996; DOI=10.1073/pnas.83.20.7721;
RA   Chan S.J., San Segundo B., McCormick M.B., Steiner D.F.;
RT   "Nucleotide and predicted amino acid sequences of cloned human and
RT   mouse preprocathepsin B cDNAs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:7721-7725(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Gastric carcinoma;
RX   PubMed=8112600; DOI=10.1016/0378-1119(94)90750-1;
RA   Cao L., Taggart R.T., Berquin I.M., Moin K., Fong D., Sloane B.F.;
RT   "Human gastric adenocarcinoma cathepsin B: isolation and sequencing of
RT   full-length cDNAs and polymorphisms of the gene.";
RL   Gene 139:163-169(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-26.
RC   TISSUE=Esophagus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS VAL-26 AND
RP   GLY-53.
RC   TISSUE=Brain, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 80-126 AND 129-333.
RC   TISSUE=Liver;
RX   PubMed=3972105; DOI=10.1016/0014-5793(85)81136-4;
RA   Ritonja A., Popovic T., Turk V., Wiedenmann K., Machleidt W.;
RT   "Amino acid sequence of human liver cathepsin B.";
RL   FEBS Lett. 181:169-172(1985).
RN   [8]
RP   PROTEIN SEQUENCE OF 80-91 AND 129-139.
RC   TISSUE=Liver;
RX   PubMed=1637335; DOI=10.1042/bj2850427;
RA   Moin K., Day N.A., Sameni M., Hasnain S., Hirama T., Sloane B.F.;
RT   "Human tumour cathepsin B. Comparison with normal liver cathepsin B.";
RL   Biochem. J. 285:427-434(1992).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 131-339.
RX   PubMed=3010323; DOI=10.1073/pnas.83.9.2909;
RA   Fong D., Calhoun D.H., Hsieh W.-T., Lee B., Wells R.D.;
RT   "Isolation of a cDNA clone for the human lysosomal proteinase
RT   cathepsin B.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:2909-2913(1986).
RN   [10]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K.,
RA   Valencia J., Muller J., Vieira W.D., Watabe H., Shabanowitz J.,
RA   Hearing V.J., Hunt D.F., Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [11]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [12]
RP   INTERACTION WITH SHKBP1, AND SUBCELLULAR LOCATION.
RX   PubMed=16733801; DOI=10.1007/s11010-006-9214-7;
RA   Liu J.P., Liu N.S., Yuan H.Y., Guo Q., Lu H., Li Y.Y.;
RT   "Human homologue of SETA binding protein 1 interacts with cathepsin B
RT   and participates in TNF-Induced apoptosis in ovarian cancer cells.";
RL   Mol. Cell. Biochem. 292:189-195(2006).
RN   [13]
RP   INTERACTION WITH SRPX2.
RX   PubMed=18718938; DOI=10.1093/hmg/ddn256;
RA   Royer-Zemmour B., Ponsole-Lenfant M., Gara H., Roll P., Leveque C.,
RA   Massacrier A., Ferracci G., Cillario J., Robaglia-Schlupp A.,
RA   Vincentelli R., Cau P., Szepetowski P.;
RT   "Epileptic and developmental disorders of the speech cortex:
RT   ligand/receptor interaction of wild-type and mutant SRPX2 with the
RT   plasminogen activator receptor uPAR.";
RL   Hum. Mol. Genet. 17:3617-3630(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS).
RX   PubMed=1868826;
RA   Musil D., Zucic D., Turk D., Engh R.A., Mayr I., Huber R., Popovic T.,
RA   Turk V., Towatari T., Katunuma N., Bode W.;
RT   "The refined 2.15 A X-ray crystal structure of human liver cathepsin
RT   B: the structural basis for its specificity.";
RL   EMBO J. 10:2321-2330(1991).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS).
RX   PubMed=8617355; DOI=10.1016/0014-5793(96)00309-2;
RA   Turk D., Podobnik M., Kuhelj R., Dolinar M., Turk V.;
RT   "Crystal structures of human procathepsin B at 3.2- and 3.3-A
RT   resolution reveal an interaction motif between a papain-like cysteine
RT   protease and its propeptide.";
RL   FEBS Lett. 384:211-214(1996).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS), AND ACTIVE SITE.
RX   PubMed=9299326; DOI=10.1006/jmbi.1997.1218;
RA   Podobnik M., Kuhelj R., Turk V., Turk D.;
RT   "Crystal structure of the wild-type human procathepsin B at 2.5-A
RT   resolution reveals the native active site of a papain-like cysteine
RT   protease zymogen.";
RL   J. Mol. Biol. 271:774-788(1997).
CC   -!- FUNCTION: Thiol protease which is believed to participate in
CC       intracellular degradation and turnover of proteins. Has also been
CC       implicated in tumor invasion and metastasis.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of proteins with broad specificity
CC       for peptide bonds. Preferentially cleaves -Arg-Arg-|-Xaa bonds in
CC       small molecule substrates (thus differing from cathepsin L). In
CC       addition to being an endopeptidase, shows peptidyl-dipeptidase
CC       activity, liberating C-terminal dipeptides.
CC   -!- SUBUNIT: Dimer of a heavy chain and a light chain cross-linked by
CC       a disulfide bond. Interacts with SRPX2. Directly interacts with
CC       SHKBP1 (PubMed:16733801). {ECO:0000269|PubMed:16733801,
CC       ECO:0000269|PubMed:18718938}.
CC   -!- INTERACTION:
CC       Q6UY14:ADAMTSL4; NbExp=3; IntAct=EBI-715062, EBI-742002;
CC       P02760:AMBP; NbExp=4; IntAct=EBI-715062, EBI-2115136;
CC       P40692:MLH1; NbExp=7; IntAct=EBI-715062, EBI-744248;
CC       Q9NYA1:SPHK1; NbExp=4; IntAct=EBI-715062, EBI-985303;
CC   -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000269|PubMed:16733801}.
CC       Melanosome. Secreted, extracellular space {ECO:0000250}.
CC       Note=Identified by mass spectrometry in melanosome fractions from
CC       stage I to stage IV.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10088, ECO:0000255|PROSITE-
CC       ProRule:PRU10089, ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CTSBID40202ch8p23.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M14221; AAA52129.1; -; mRNA.
DR   EMBL; L16510; AAC37547.1; -; mRNA.
DR   EMBL; AK092070; BAG52477.1; -; mRNA.
DR   EMBL; AK075393; BAG52127.1; -; mRNA.
DR   EMBL; CH471157; EAW65630.1; -; Genomic_DNA.
DR   EMBL; BC010240; AAH10240.1; -; mRNA.
DR   EMBL; BC095408; AAH95408.1; -; mRNA.
DR   EMBL; M13230; AAA52125.1; -; mRNA.
DR   CCDS; CCDS5986.1; -.
DR   PIR; A26498; KHHUB.
DR   RefSeq; NP_001899.1; NM_001908.4.
DR   RefSeq; NP_680090.1; NM_147780.3.
DR   RefSeq; NP_680091.1; NM_147781.3.
DR   RefSeq; NP_680092.1; NM_147782.3.
DR   RefSeq; NP_680093.1; NM_147783.3.
DR   RefSeq; XP_006716307.1; XM_006716244.2.
DR   RefSeq; XP_006716308.1; XM_006716245.2.
DR   RefSeq; XP_011542114.1; XM_011543812.2.
DR   RefSeq; XP_016868586.1; XM_017013097.1.
DR   RefSeq; XP_016868587.1; XM_017013098.1.
DR   RefSeq; XP_016868588.1; XM_017013099.1.
DR   RefSeq; XP_016868589.1; XM_017013100.1.
DR   UniGene; Hs.520898; -.
DR   PDB; 1CSB; X-ray; 2.00 A; A/D=80-126, B/E=129-333.
DR   PDB; 1GMY; X-ray; 1.90 A; A/B/C=79-339.
DR   PDB; 1HUC; X-ray; 2.10 A; A/C=80-126, B/D=129-333.
DR   PDB; 1PBH; X-ray; 3.20 A; A=18-333.
DR   PDB; 2IPP; X-ray; 2.15 A; A=80-126, B=129-333.
DR   PDB; 2PBH; X-ray; 3.30 A; A=18-333.
DR   PDB; 3AI8; X-ray; 2.11 A; A/B=78-333.
DR   PDB; 3CBJ; X-ray; 1.80 A; A=74-339.
DR   PDB; 3CBK; X-ray; 2.67 A; A=74-339.
DR   PDB; 3K9M; X-ray; 2.61 A; A/B=80-333.
DR   PDB; 3PBH; X-ray; 2.50 A; A=18-333.
DR   PDBsum; 1CSB; -.
DR   PDBsum; 1GMY; -.
DR   PDBsum; 1HUC; -.
DR   PDBsum; 1PBH; -.
DR   PDBsum; 2IPP; -.
DR   PDBsum; 2PBH; -.
DR   PDBsum; 3AI8; -.
DR   PDBsum; 3CBJ; -.
DR   PDBsum; 3CBK; -.
DR   PDBsum; 3K9M; -.
DR   PDBsum; 3PBH; -.
DR   ProteinModelPortal; P07858; -.
DR   SMR; P07858; -.
DR   BioGrid; 107888; 35.
DR   DIP; DIP-42785N; -.
DR   IntAct; P07858; 39.
DR   MINT; MINT-1397666; -.
DR   STRING; 9606.ENSP00000342070; -.
DR   BindingDB; P07858; -.
DR   ChEMBL; CHEMBL4072; -.
DR   DrugBank; DB02108; 2-Aminoethanimidic Acid.
DR   DrugBank; DB03329; 2-Pyridinethiol.
DR   DrugBank; DB02148; 3-Amino-4-Oxybenzyl-2-Butanone.
DR   DrugBank; DB02685; 3-Methylphenylalanine.
DR   DrugBank; DB03588; Diphenylacetic Acid.
DR   DrugBank; DB02855; N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline.
DR   DrugBank; DB04126; N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane.
DR   GuidetoPHARMACOLOGY; 2343; -.
DR   MEROPS; C01.060; -.
DR   iPTMnet; P07858; -.
DR   PhosphoSitePlus; P07858; -.
DR   SwissPalm; P07858; -.
DR   BioMuta; CTSB; -.
DR   DMDM; 68067549; -.
DR   SWISS-2DPAGE; P07858; -.
DR   UCD-2DPAGE; P07858; -.
DR   EPD; P07858; -.
DR   MaxQB; P07858; -.
DR   PaxDb; P07858; -.
DR   PeptideAtlas; P07858; -.
DR   PRIDE; P07858; -.
DR   TopDownProteomics; P07858; -.
DR   DNASU; 1508; -.
DR   Ensembl; ENST00000345125; ENSP00000342070; ENSG00000164733.
DR   Ensembl; ENST00000353047; ENSP00000345672; ENSG00000164733.
DR   Ensembl; ENST00000453527; ENSP00000409917; ENSG00000164733.
DR   Ensembl; ENST00000530640; ENSP00000435105; ENSG00000164733.
DR   Ensembl; ENST00000531089; ENSP00000433215; ENSG00000164733.
DR   Ensembl; ENST00000533455; ENSP00000432244; ENSG00000164733.
DR   Ensembl; ENST00000534510; ENSP00000434217; ENSG00000164733.
DR   GeneID; 1508; -.
DR   KEGG; hsa:1508; -.
DR   UCSC; uc003wun.4; human.
DR   CTD; 1508; -.
DR   DisGeNET; 1508; -.
DR   GeneCards; CTSB; -.
DR   H-InvDB; HIX0007320; -.
DR   HGNC; HGNC:2527; CTSB.
DR   HPA; CAB000457; -.
DR   HPA; HPA018156; -.
DR   MIM; 116810; gene.
DR   neXtProt; NX_P07858; -.
DR   OpenTargets; ENSG00000164733; -.
DR   PharmGKB; PA27027; -.
DR   eggNOG; KOG1543; Eukaryota.
DR   eggNOG; COG4870; LUCA.
DR   GeneTree; ENSGT00780000121937; -.
DR   HOGENOM; HOG000241341; -.
DR   HOVERGEN; HBG003480; -.
DR   InParanoid; P07858; -.
DR   KO; K01363; -.
DR   OMA; EDMLTCC; -.
DR   OrthoDB; EOG091G094Z; -.
DR   PhylomeDB; P07858; -.
DR   TreeFam; TF314576; -.
DR   BRENDA; 3.4.22.1; 2681.
DR   Reactome; R-HSA-1442490; Collagen degradation.
DR   Reactome; R-HSA-1679131; Trafficking and processing of endosomal TLR.
DR   Reactome; R-HSA-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   ChiTaRS; CTSB; human.
DR   EvolutionaryTrace; P07858; -.
DR   GeneWiki; Cathepsin_B; -.
DR   GenomeRNAi; 1508; -.
DR   PMAP-CutDB; P07858; -.
DR   PRO; PR:P07858; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000164733; -.
DR   CleanEx; HS_CTSB; -.
DR   ExpressionAtlas; P07858; baseline and differential.
DR   Genevisible; P07858; HS.
DR   GO; GO:0036021; C:endolysosome lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0005622; C:intracellular; TAS:ProtInc.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005518; F:collagen binding; IDA:BHF-UCL.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IDA:BHF-UCL.
DR   GO; GO:0008234; F:cysteine-type peptidase activity; IDA:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; IDA:BHF-UCL.
DR   GO; GO:0043394; F:proteoglycan binding; IPI:BHF-UCL.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; TAS:Reactome.
DR   GO; GO:0097067; P:cellular response to thyroid hormone stimulus; IEP:UniProtKB.
DR   GO; GO:0030574; P:collagen catabolic process; IDA:BHF-UCL.
DR   GO; GO:0046697; P:decidualization; IEA:Ensembl.
DR   GO; GO:0030855; P:epithelial cell differentiation; IEP:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:BHF-UCL.
DR   GO; GO:0042981; P:regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0050790; P:regulation of catalytic activity; IEA:InterPro.
DR   GO; GO:0002224; P:toll-like receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0046718; P:viral entry into host cell; IEA:Ensembl.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR013128; Peptidase_C1A.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR015643; Peptidase_C1A_cathepsin-B.
DR   InterPro; IPR012599; Propeptide_C1A.
DR   PANTHER; PTHR12411; PTHR12411; 1.
DR   PANTHER; PTHR12411:SF480; PTHR12411:SF480; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   Pfam; PF08127; Propeptide_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00645; Pept_C1; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Hydrolase;
KW   Lysosome; Polymorphism; Protease; Reference proteome; Secreted;
KW   Signal; Thiol protease; Zymogen.
FT   SIGNAL        1     17       {ECO:0000255}.
FT   PROPEP       18     79       Activation peptide.
FT                                {ECO:0000269|PubMed:3972105}.
FT                                /FTId=PRO_0000026143.
FT   CHAIN        80    333       Cathepsin B.
FT                                /FTId=PRO_0000026144.
FT   CHAIN        80    126       Cathepsin B light chain.
FT                                {ECO:0000269|PubMed:3972105}.
FT                                /FTId=PRO_0000026145.
FT   CHAIN       129    333       Cathepsin B heavy chain.
FT                                {ECO:0000269|PubMed:3972105}.
FT                                /FTId=PRO_0000026146.
FT   PROPEP      334    339
FT                                /FTId=PRO_0000026147.
FT   ACT_SITE    108    108       {ECO:0000269|PubMed:9299326}.
FT   ACT_SITE    278    278       {ECO:0000269|PubMed:9299326}.
FT   ACT_SITE    298    298       {ECO:0000269|PubMed:9299326}.
FT   MOD_RES     220    220       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P10605}.
FT   CARBOHYD    192    192       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:3463996}.
FT   DISULFID     93    122       {ECO:0000269|PubMed:1868826}.
FT   DISULFID    105    150       {ECO:0000269|PubMed:1868826}.
FT   DISULFID    141    207       {ECO:0000269|PubMed:1868826}.
FT   DISULFID    142    146       {ECO:0000269|PubMed:1868826}.
FT   DISULFID    179    211       {ECO:0000269|PubMed:1868826}.
FT   DISULFID    187    198       {ECO:0000269|PubMed:1868826}.
FT   VARIANT      26     26       L -> V (in dbSNP:rs12338).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:3463996}.
FT                                /FTId=VAR_006724.
FT   VARIANT      53     53       S -> G (in dbSNP:rs1803250).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_051511.
FT   VARIANT      91     91       P -> L (in dbSNP:rs11548596).
FT                                /FTId=VAR_051512.
FT   VARIANT     235    235       S -> N (in dbSNP:rs17573).
FT                                /FTId=VAR_014696.
FT   CONFLICT    228    228       N -> D (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       82     85       {ECO:0000244|PDB:1GMY}.
FT   HELIX        86     89       {ECO:0000244|PDB:3CBJ}.
FT   HELIX        94     97       {ECO:0000244|PDB:3CBJ}.
FT   STRAND      104    106       {ECO:0000244|PDB:3CBJ}.
FT   HELIX       108    124       {ECO:0000244|PDB:3CBJ}.
FT   TURN        125    127       {ECO:0000244|PDB:3CBJ}.
FT   STRAND      131    133       {ECO:0000244|PDB:3K9M}.
FT   HELIX       135    141       {ECO:0000244|PDB:3CBJ}.
FT   HELIX       143    146       {ECO:0000244|PDB:3CBJ}.
FT   HELIX       149    151       {ECO:0000244|PDB:1GMY}.
FT   HELIX       155    164       {ECO:0000244|PDB:3CBJ}.
FT   STRAND      167    170       {ECO:0000244|PDB:3PBH}.
FT   TURN        173    175       {ECO:0000244|PDB:3CBK}.
FT   STRAND      178    180       {ECO:0000244|PDB:3CBJ}.
FT   STRAND      188    191       {ECO:0000244|PDB:1GMY}.
FT   STRAND      193    195       {ECO:0000244|PDB:2IPP}.
FT   HELIX       220    222       {ECO:0000244|PDB:3CBJ}.
FT   STRAND      226    231       {ECO:0000244|PDB:1CSB}.
FT   HELIX       236    246       {ECO:0000244|PDB:3CBJ}.
FT   STRAND      249    256       {ECO:0000244|PDB:3CBJ}.
FT   HELIX       257    261       {ECO:0000244|PDB:3CBJ}.
FT   STRAND      264    267       {ECO:0000244|PDB:3CBJ}.
FT   STRAND      274    288       {ECO:0000244|PDB:3CBJ}.
FT   STRAND      291    297       {ECO:0000244|PDB:3CBJ}.
FT   STRAND      302    304       {ECO:0000244|PDB:2IPP}.
FT   STRAND      309    313       {ECO:0000244|PDB:3CBJ}.
FT   TURN        314    317       {ECO:0000244|PDB:2PBH}.
FT   HELIX       318    320       {ECO:0000244|PDB:3CBJ}.
FT   TURN        321    323       {ECO:0000244|PDB:3CBJ}.
FT   STRAND      326    330       {ECO:0000244|PDB:1CSB}.
SQ   SEQUENCE   339 AA;  37822 MW;  0FC818EA4C1F6D90 CRC64;
     MWQLWASLCC LLVLANARSR PSFHPLSDEL VNYVNKRNTT WQAGHNFYNV DMSYLKRLCG
     TFLGGPKPPQ RVMFTEDLKL PASFDAREQW PQCPTIKEIR DQGSCGSCWA FGAVEAISDR
     ICIHTNAHVS VEVSAEDLLT CCGSMCGDGC NGGYPAEAWN FWTRKGLVSG GLYESHVGCR
     PYSIPPCEHH VNGSRPPCTG EGDTPKCSKI CEPGYSPTYK QDKHYGYNSY SVSNSEKDIM
     AEIYKNGPVE GAFSVYSDFL LYKSGVYQHV TGEMMGGHAI RILGWGVENG TPYWLVANSW
     NTDWGDNGFF KILRGQDHCG IESEVVAGIP RTDQYWEKI
//
